ILMN  valuation analysis

Basics
Name: Illumina, Inc
Description: Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 27, 2021
Market cap: $67.52B (115th)
Sales(TTM): $3.47B (566th)
Earnings(TTM): $630.00M (338th)

Value
FFER: 6.13*
Actual price: $462.49
* Earnings were reported Aug 05, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Illumina, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Illumina, Inc
"Diagnostics & Research" industry
Book / MarketCap
Illumina, Inc
"Diagnostics & Research" industry
Equity / Assets
Illumina, Inc
"Diagnostics & Research" industry